Biotechnology Health Law Policy Intellectual Property Judicial Opinions Market Design Pharmaceuticals Professional Regulation Scientific Evidence Supreme Court The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients Read more: The SCOTUS Antibody Ruling Has an Uncertain Impact for Drug Makers and Patients
Antitrust Featured Generic Drugs Greg Curfman Health Law Policy Intellectual Property Pharmaceuticals Public Health 3 Challenges to Patents on Therapeutic Monoclonal Antibodies Read more: 3 Challenges to Patents on Therapeutic Monoclonal Antibodies
Antitrust Featured Health Law Policy Intellectual Property Laura Karas Pharmaceuticals When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims Read more: When “Pay-for-Delay” Becomes “Delay-Without-Pay”: Humira Antitrust Claims
Antitrust Generic Drugs Health Law Policy Intellectual Property Pharmaceuticals Public Health AbbVie Wins First Round in Humira Antitrust Lawsuit Read more: AbbVie Wins First Round in Humira Antitrust Lawsuit